Wegovy’s Potential Heart Benefit Factors into Coverage Decisions

Health benefits prompt employers to cover expensive meds

Early findings from a study by Novo Nordisk found that Wegovy can decrease the risk of cardiovascular events by 20%, which is causing some large employers to take a look at adding AOMs to their coverage. With Intellihealth, the state of Connecticut has started a program for its employees that it expects will yield reduced medical costs and improved health outcomes.

Read more at Bloomberg (pdf)